Please ensure Javascript is enabled for purposes of website accessibility

Stocks for the Long Run: West Pharmaceutical Services vs. the S&P 500

By Motley Fool Staff – Updated Apr 7, 2017 at 12:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A long history of returns.

Investing isn't easy. Even Warren Buffett counsels that most investors should invest in a low-cost index like the S&P 500. That way, "you'll be buying into a wonderful industry, which in effect is all of American industry," he says.

But there are, of course, companies whose long-term fortunes differ substantially from the index. In this series, we look at how individual stocks have performed against the broad S&P 500.

Step on up, West Pharmaceutical Services (NYSE: WST).         

West Pharmaceutical Services shares have roughly matched the S&P 500 over the last quarter-century:

Source: S&P Capital IQ.

Since 1987, shares have returned an average of 10.1% a year, compared with 9.7% a year for the S&P (both include dividends). One thousand dollars invested in the S&P in 1987 would be worth $19,200 today, and, naturally, about the same in West Pharmaceutical Services.

Dividends accounted for a lot of those gains. Compounded since 1987, dividends have made up about half of West Pharmaceutical Services' total returns. For the S&P, dividends account for 39% of total returns.

Now have a look at how West Pharmaceutical Services earnings compare with S&P 500 earnings:

Source: S&P Capital IQ.

Again, pretty average. Since 1995, West Pharmaceutical Services earnings per share have increased by 5.6% per year, compared with 6% a year for the broader index. 

What's that meant for valuations? West Pharmaceutical Services has traded for an average of 20 times earnings since 1987 -- below the 24 times earnings of the broader S&P 500.

Through it all, shares have been mediocre performers over the last quarter-century.  

Of course, the important question is whether that will continue. That's where you come in. Our CAPS community currently ranks West Pharmaceutical Services with a three-star rating (out of five). Care to disagree? Leave your thoughts in the comment section below, or add West Pharmaceutical Services to My Watchlist.

Fool contributor Morgan Housel doesn't own shares in any of the companies mentioned in this article. Follow him on Twitter @TMFHousel. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

West Pharmaceutical Services, Inc. Stock Quote
West Pharmaceutical Services, Inc.
WST
$246.08 (-2.07%) $-5.19

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.